Hearing Marks One-Year of Committee’s Bipartisan Investigation
WASHINGTON, DC – The Subcommittee on Oversight and Investigations, chaired by Rep. Gregg Harper (R-MS), announced a hearing with the leadership of national and regional drug distributors in regards to the committee’s bipartisan investigation into alleged pill dumping in West Virginia. The hearing will be held on Tuesday, May 8, 2018, marking exactly one year since the committee’s initial requests for information. More information regarding the time and location will be posted here as it becomes available.
#SubOversight has confirmed the following witnesses will testify:
- Mr. John Hammergren, Chairman, President and CEO, McKesson Corporation;
- Mr. George Barrett, Executive Chairman of the Board, Cardinal Health Inc.;
- Mr. Steven Collis, Chairman, President and CEO, AmerisourceBergen Corporation;
- Dr. Joseph Mastandrea, Chairman of the Board, Miami-Luken, Inc.; and
- Mr. J. Christopher Smith, former President and CEO, H.D. Smith Wholesale Drug Company.
Bipartisan committee leaders first requested information from the nation’s “big three” distributors – AmerisourceBergen, Cardinal Health, and McKesson – on May 8, 2017. In September 2017, the committee probed a fourth distributor, Miami-Luken. In January 2018, the committee sent a follow-up letter to Miami-Luken and probed a fifth distributor, H.D. Smith. In February 2018, the committee sent follow-up questions to AmerisourceBergen, Cardinal Health, and McKesson. For a full timeline of the committee’s bipartisan investigation, click here.
“For one year, the entire committee – Republicans and Democrats – have pressed five distributors with a presence in West Virginia, as well as the Drug Enforcement Administration (DEA) for answers as to how tremendous amounts of pills ended up in these small communities,” said #SubOversight Chairman Harper. “Today, we have a more complete picture of what happened in places like West Virginia, and we will hold all parties accountable for their actions. I, along with my colleagues, urge our witnesses to help us complete this puzzle so we can ensure this will never happen again.”
Last month, #SubOversight questioned DEA’s Acting Administrator, Robert Patterson, about his agency’s role in combating the opioid crisis, particularly during the time of the alleged pill dumping in West Virginia.